about
Estimating the measles effective reproduction number in Australia from routine notification data.Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyA new method for assessing how sensitivity and specificity of linkage studies affects estimationThe ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.National serosurvey of cytomegalovirus in AustraliaQ Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.Influenza related hospitalisations in Sydney, New South Wales, Australia.Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men.Poor record linkage sensitivity biased outcomes in a linked cohort analysis.Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men.Hepatitis C treatment outcomes in Australian clinics.Establishing a process for conducting cross-jurisdictional record linkage in Australia.Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points.Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.Verification of measles elimination in Australia: Application of World Health Organization regional guidelines.The seroepidemiology of Helicobacter pylori infection in Australia.Risk factors and burden of acute Q fever in older adults in New South Wales: a prospective cohort study.Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys.Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men.Febrile seizures following measles and varicella vaccines in young children in Australia.Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.Rapid identification of group B streptococcus carriage by PCR to assist in the management of women with prelabour rupture of membranes in term pregnancy.Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia.Could it be Q fever?Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection.Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia.Estimates of chronic hepatitis B virus infection in Australia, 2000.The seroepidemiology and transmission dynamics of varicella in Australia.Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future - CORRIGENDUM.Declining measles antibodies in the era of elimination: Australia's experience.Laboratory surveillance of invasive pneumococcal disease in New South Wales, Australia, before and after introduction of 7-valent conjugate vaccine: reduced disease, but not antibiotic resistance rates.Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia.Australian rubella serosurvey 2012-2013: On track for elimination?Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
P50
Q30793607-015B1887-9747-4A58-8111-A6AC17136027Q33287061-6089DDCF-A90A-4B2A-9A4C-10DB0FFA73F3Q33801743-85C6899B-71AC-45DE-B8BD-F250B6F2E74CQ33961730-FCAABDB8-68BC-4FBD-A001-47EF1CB8F083Q34325764-C6A270F9-9A66-42F0-8DF9-4280912E6A5DQ35160692-C49E3E08-4EA0-4240-8F9C-9440F6D26B8FQ35891438-B26A8549-1C1D-464D-8F0D-E2C45C878BABQ36153678-F75757EE-3AF0-4AC9-AEB0-79A9840F100EQ36656015-89D501F2-73CC-41B4-AC58-9DF8D2241FFFQ37026512-025BB8DD-5CB0-47D5-868B-C236929A37E0Q37853014-0E118AAA-7F53-404D-8AC9-2B8E3B36CCC8Q38016986-C7B7A370-AE05-4898-87C4-66A7EB37CC14Q38943747-E1507390-636D-4795-997C-280625B51355Q39128973-0CFD8FA7-FC02-41F1-9448-F2C96AA7F5F7Q39573737-FBA005D0-33D2-4132-82BD-95CB5BF21299Q39984667-D2AEF780-118A-464A-8D3F-3C96BFA29F95Q40041266-E17848EC-622F-4EAC-BB8C-D11C5325E8A7Q40104634-03C8DB08-D650-425F-9081-56EEFD4A210AQ40127541-198597FD-0155-4DFA-BB01-88DBB5D1D2C3Q40451328-8A55C111-BA7B-44F2-9A08-BCF7BB893163Q41534351-D32C58F6-ECBE-4CC3-ADCE-72A92D7DE5CDQ41629156-871E7BBF-BA43-4766-9770-E28C034D16B2Q41637575-C6A8D757-91DE-477A-B143-6D89B2850E56Q41688695-C7E3ACEC-C4B2-496F-993B-272D4186D7B2Q42226764-3C19AA3A-C27C-47AA-AD2D-4E8A57DF5F69Q43071659-C9E3BA51-7E8B-45A5-9FA0-5E4E88593C8BQ44579202-9989D9B3-FFA3-474B-A81A-AA808B27C518Q44917702-FBC36123-6F77-486C-B48C-AC97F3690704Q45085512-3A684D01-598B-4C1D-BD3E-D22F3791E817Q45326018-79F7DCA1-6897-4B5E-97C1-2D8298F38471Q45326895-FF31997B-7FD2-469D-92E4-D0926FFFD0BDQ45512396-3BEA26B1-6B18-4E15-8DAA-197C785E703AQ47208922-F9EA80E8-67A9-4691-AA2A-D91D31B204AAQ48579634-54E1F80A-9E44-4971-959D-91E76F2F4C93Q50134886-A75A3454-B1E4-4475-B4F6-5E1A28980553Q51193414-2EBCBF01-54F2-46D2-A550-E806C751A5CCQ51790294-E303178E-A7BE-4E86-BE6B-170618FBA5F1Q51972350-04F501C2-1B33-45EF-B100-2243EF129195Q52584865-F2720B92-13C7-4FEE-913B-E9C19A1709EAQ54240067-50FE7A05-0AA4-4BFF-BC57-6856533B65DE
P50
description
researcher ORCID ID = 0000-0001-7595-9281
@en
wetenschapper
@nl
name
Heather F Gidding
@ast
Heather F Gidding
@en
Heather F Gidding
@es
Heather F Gidding
@nl
type
label
Heather F Gidding
@ast
Heather F Gidding
@en
Heather F Gidding
@es
Heather F Gidding
@nl
prefLabel
Heather F Gidding
@ast
Heather F Gidding
@en
Heather F Gidding
@es
Heather F Gidding
@nl
P106
P1153
6701578494
P31
P496
0000-0001-7595-9281